We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$216M
2
CPT icon
Camden Property Trust
CPT
+$180M
3
AMT icon
American Tower
AMT
+$137M
4
PLD icon
Prologis
PLD
+$122M
5
EXR icon
Extra Space Storage
EXR
+$90.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$181M
2
AVB icon
AvalonBay Communities
AVB
+$166M
3
HST icon
Host Hotels & Resorts
HST
+$163M
4
REG icon
Regency Centers
REG
+$134M
5
ESS icon
Essex Property Trust
ESS
+$92.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QNCX icon
1301
Quince Therapeutics
QNCX
$18.9M
$1K ﹤0.01%
1
– –
RANI icon
1302
Rani Therapeutics
RANI
$92.1M
$1K ﹤0.01%
58
– –
RIGL icon
1303
Rigel Pharmaceuticals
RIGL
$712M
$1K ﹤0.01%
37
– –
RLYB icon
1304
Rallybio
RLYB
$85.7M
$1K ﹤0.01%
12
– –
RPID icon
1305
Rapid Micro Biosystems
RPID
$103M
$1K ﹤0.01%
101
– –
SIGA icon
1306
SIGA Technologies
SIGA
$240M
$1K ﹤0.01%
172
– –
SMMT icon
1307
Summit Therapeutics
SMMT
$10B
$1K ﹤0.01%
334
– –
SPRO icon
1308
Spero Therapeutics
SPRO
$69.2M
$1K ﹤0.01%
110
– –
STRO icon
1309
Sutro Biopharma
STRO
$393M
$1K ﹤0.01%
16
– –
STTK icon
1310
Shattuck Labs
STTK
$651M
$1K ﹤0.01%
123
– –
TKNO icon
1311
Alpha Teknova
TKNO
$273M
$1K ﹤0.01%
82
– –
TNYA icon
1312
Tenaya Therapeutics
TNYA
$164M
$1K ﹤0.01%
120
– –
TRML
1313
DELISTED
Tourmaline Bio
TRML
$1K ﹤0.01%
12
– –
TSHA icon
1314
Taysha Gene Therapies
TSHA
$1.57B
$1K ﹤0.01%
112
– –
VOR icon
1315
Vor Biopharma
VOR
$1.08B
$1K ﹤0.01%
5
– –
W icon
1316
PUT
Wayfair
W
$12.5B
$1K ﹤0.01%
+50
New +$7.04K
XERS icon
1317
Xeris Biopharma Holdings
XERS
$1.42B
$1K ﹤0.01%
404
+302
+296% +$738
LENZ
1318
LENZ Therapeutics
LENZ
$184M
$1K ﹤0.01%
24
– –
CMRX
1319
DELISTED
Chimerix, Inc.
CMRX
$1K ﹤0.01%
253
– –
OMGA
1320
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1K ﹤0.01%
139
– –
PSTX
1321
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1K ﹤0.01%
116
– –
EGRX
1322
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
– –
GTHX
1323
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1K ﹤0.01%
145
– –
OMIC
1324
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1K ﹤0.01%
7
– –
ALPN
1325
DELISTED
Alpine Immune Sciences Inc
ALPN
$1K ﹤0.01%
85
– –
51 52
53
54 55

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.